News from other sources
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content
Payers
A tale of two CT scanners—one richer, one poorer | Kaiser Health News
Tests tend to be more expensive in hospitals.
Pharmaceuticals
Novartis bets big on gene therapy with $8.7 billion AveXis deal | Reuters
AveXis makes a gene-therapy drug for spinal muscular atrophy. Earlier this year, Novartis bought the non-U.S. rights to Spark's Luxturna, a gene-therapy treatment for blindness.
The strange story of a global pharma company's Silicon Valley winery | Stat
Besides bringing in money from drugs for leukemia, schizophrenia, and other conditions, Japanese pharmaceutical Otsuka also brings in cash from cabernet sauvignon.
Information technology
Sequoia Project starts program to share patient data during disasters | Health Data Management
Sequoia Project leaders want to build a Patient Unified Lookup System for Emergencies so providers can get patients' health information during disasters. The public-private collaborative would make it so providers could get access to continuity of care documents during emergencies.
In other news
Many people taking antidepressants discover they cannot quit | The New York Times
More than 15 million Americans have been taking antidepressants for more than five years. But when it's time to quit, some find they can't, as they're plagued by withdrawal symptoms they didn't even know existed.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 |